Monoclonal Antibody Dupilumab Safe And Effective In Asthma Phase IIa Trial
A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to researchers.
The randomized, double…